- FDA claims trial 'manipulation' tainted approval of ChemoCentryx drugThe FDA accused ChemoCentryx of manipulating the results of a pivotal clinical trial used to approve the drug Tavneos, escalating the agency's effort to pull the treatment from the market. "New i…Endpoints · 3mo ago↗ source
- Devoted Health’s 2025 revenue slips in turbulent Medicare Advantage marketDevoted Health’s revenue and membership declined in 2025 for the first time since it launched health plans for seniors seven years ago. It’s a sign the high-profile startup, helmed by former Athe…Endpoints · 3mo ago↗ source
- Adaptyv Bio reveals latest results in protein design competitionRIO DE JANEIRO, Brazil — For the past two years, Adaptyv Bio has challenged the AI community to see how good today’s models are at designing proteins. Its latest competition, presented Monday at a…